- Home
- SEV vs NYXH Comparison
SEV vs NYXH Comparison
Compare SEV & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEV
- NYXH
- Stock Information
- Founded
- SEV 2019
- NYXH 2009
- Country
- SEV United States
- NYXH Belgium
- Employees
- SEV N/A
- NYXH N/A
- Industry
- SEV Auto Manufacturing
- NYXH Medical/Dental Instruments
- Sector
- SEV Industrials
- NYXH Health Care
- Exchange
- SEV Nasdaq
- NYXH Nasdaq
- Market Cap
- SEV 189.2M
- NYXH 188.1M
- IPO Year
- SEV N/A
- NYXH 2021
- Fundamental
- Price
- SEV $6.69
- NYXH $4.68
- Analyst Decision
- SEV
- NYXH Strong Buy
- Analyst Count
- SEV 0
- NYXH 3
- Target Price
- SEV N/A
- NYXH $12.67
- AVG Volume (30 Days)
- SEV 438.3K
- NYXH 35.8K
- Earning Date
- SEV 11-17-2025
- NYXH 11-13-2025
- Dividend Yield
- SEV N/A
- NYXH N/A
- EPS Growth
- SEV N/A
- NYXH N/A
- EPS
- SEV N/A
- NYXH N/A
- Revenue
- SEV N/A
- NYXH $6,616,215.00
- Revenue This Year
- SEV N/A
- NYXH $85.62
- Revenue Next Year
- SEV N/A
- NYXH $320.09
- P/E Ratio
- SEV N/A
- NYXH N/A
- Revenue Growth
- SEV N/A
- NYXH 10.96
- 52 Week Low
- SEV $3.55
- NYXH $4.35
- 52 Week High
- SEV $22.43
- NYXH $11.87
- Technical
- Relative Strength Index (RSI)
- SEV N/A
- NYXH 37.47
- Support Level
- SEV N/A
- NYXH $4.74
- Resistance Level
- SEV N/A
- NYXH $5.92
- Average True Range (ATR)
- SEV 0.00
- NYXH 0.26
- MACD
- SEV 0.00
- NYXH -0.05
- Stochastic Oscillator
- SEV 0.00
- NYXH 0.76
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.